197
Views
8
CrossRef citations to date
0
Altmetric
Review

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

, &
Pages 457-464 | Published online: 26 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

M. Raschid Hoda, Mario W. Kramer, Axel S. Merseburger & Marcus V. Cronauer. (2017) Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer. Expert Opinion on Pharmacotherapy 18:1, pages 105-113.
Read now

Articles from other publishers (7)

Xingjiang Hu, Qiao Zhang, Yunliang Zheng, You Zhai, Nana Xu, Qingwei Zhao, Jian Liu, Longyan Wan & Jindan Luo. (2022) A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone® 3.75 mg in healthy male subjects. Frontiers in Pharmacology 13.
Crossref
Fang Yu, Tingting Zhang, Fenghua Fu, Aiping Wang & Xinyong Liu. (2022) Preparation of Long-Acting Somatostatin and GnRH Analogues and Their Applications in Tumor Therapy. Current Drug Delivery 19:1, pages 5-16.
Crossref
Mian Fu, Xiaomei Zhuang, Tianhong Zhang, Ying Guan, Qingbin Meng & Yongjun Zhang. (2020) Hydrogen‐Bonded Films for Zero‐Order Release of Leuprolide. Macromolecular Bioscience 20:9.
Crossref
Greg Troiano, Jim Nolan, Donald Parsons, Christina Van Geen Hoven & Stephen Zale. (2016) A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products. The AAPS Journal 18:6, pages 1354-1365.
Crossref
Kazuhiro Suzuki, Mikio Namiki, Tsukasa Fujimoto, Nobuyoshi Takabayashi, Kentarou Kudou & Hideyuki Akaza. (2015) Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan. Japanese Journal of Clinical Oncology, pages hyv149.
Crossref
Susan D’Souza, Santos Murty, Jabar A. Faraj & Patrick P. DeLuca. (2014) In Vitro Characterization of Six Month Dosage Forms for a GnRH Antagonist . Advances in Pharmaceutics 2014, pages 1-10.
Crossref
Gábor Mezo. 2013. Amino Acids, Peptides and Proteins. Amino Acids, Peptides and Proteins 203 252 .